PHF5A promotes colorectal cancer progression by alternative splicing of TEAD2Yue Chang, Cheng Chen, Liya Wang et al.|Molecular Therapy — Nucleic Acids|2021Cited by 42
Metapristone (RU486-derivative) inhibits endometrial cancer cell progress through regulating miR-492/Klf5/Nrf1 axisYue Chang, Yun Liu|Research Square|2020Cited by 0
Metapristone (RU486-derivative) inhibits endometrial cancer cell progress through regulating miR-492/Klf5/Nrf1 axisYue Chang, Yun Liu|Research Square|2020Cited by 0
Metapristone (RU486 derivative) inhibits endometrial cancer cell progress through regulating miR-492/Klf5/Nrf1 axisYue Chang, Yun Liu|Research Square|2020Cited by 0